Regeneron Teaming With Roche On Coronavirus Treatment; Adds CapacityInvestors Business Daily • 08/19/20
Regeneron To Collaborate With Roche For Global Supply Of Its Coronavirus TreatmentBenzinga • 08/19/20
Roche and Regeneron collaborate to significantly increase global supply of REGN-COV2 investigational antibody combination for COVID-19GlobeNewsWire • 08/19/20
Genentech and Regeneron Collaborate to Significantly Increase Global Supply of REGN-COV2 Investigational Antibody Combination for COVID-19Business Wire • 08/19/20
FDA Approves Roche’s ENSPRYNG for Neuromyelitis Optica Spectrum Disorder (NMOSD)GlobeNewsWire • 08/17/20
FDA approves Roche’s Evrysdi (risdiplam) for treatment of spinal muscular atrophy (SMA) in adults and children 2 months and olderGlobeNewsWire • 08/10/20
Roche provides update on phase III studies of etrolizumab in people with moderately to severely active ulcerative colitisGlobeNewsWire • 08/10/20
Roche provides update on Phase III study of Tecentriq in combination with paclitaxel for people with metastatic triple-negative breast cancerGlobeNewsWire • 08/06/20
Roche announces FDA authorisation for the first Epstein-Barr virus quantitative test on the cobas 6800/8800 Systems to improve care for transplant patientsGlobeNewsWire • 08/05/20
Rozlytrek, Roche’s first tumour-agnostic therapy, approved in Europe for people with NTRK fusion-positive solid tumours and for people with ROS1-positive advanced non-small cell lung cancerGlobeNewsWire • 08/03/20
FDA approves Roche’s Tecentriq plus Cotellic and Zelboraf for people with advanced melanomaGlobeNewsWire • 07/31/20
Roche launches cobas prime Pre-analytical System, a first-of-its-kind solution designed to automate all common manual steps in molecular diagnostics laboratoriesPRNewsWire • 07/30/20
The Hanover Insurance Group, Inc. (THG) CEO John Roche on Q2 2020 Results - Earnings Call TranscriptSeeking Alpha • 07/29/20
FDA approves Roche’s new VENTANA HER2 Dual ISH test as companion diagnostic to identify breast cancer patients eligible for targeted therapyGlobeNewsWire • 07/29/20
Roche provides an update on the phase III COVACTA trial of Actemra/RoActemra in hospitalised patients with severe COVID-19 associated pneumoniaGlobeNewsWire • 07/29/20